Lv4
614 积分 2022-06-12 加入
Stereotactic ablative body radiotherapy for PSMA-PET/CT staged, oligometastatic prostate cancer - A multi-centre study
19天前
已完结
Direct Treatment of All Visible Tumour in Synchronous Oligometastatic Prostate Cancer: Total Eradication of Tumour or the Full Monty Treatment
24天前
已完结
A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study
24天前
已完结
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer
25天前
已完结
Prostatectomy and other local treatments for oligometastatic prostate cancer: recent and ongoing trials
25天前
已完结
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)
2个月前
已完结
Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer
2个月前
已关闭
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer
3个月前
已完结
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)
5个月前
已完结
Effect of tumor CD276 expression on infiltrating immune cells and clinicopathological features of prostate cancer
5个月前
已完结
皖公网安备34019202002308
